Evofem Biosciences (EVFM) EBITDA Margin (2020 - 2026)
Evofem Biosciences (EVFM) reported EBITDA Margin of -93.85% for Q2 2026, down 70.22 percentage points from -23.63% a year earlier but up 402.82 percentage points from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Evofem Biosciences' EBITDA Margin came in at -13.53%, up 6.14 percentage points year-over-year; for FY2025, it came in at 19.28%, up 55.57 percentage points from FY2024.
- EBITDA Margin has increased for five consecutive years, with a five-year change of +23185.65 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -36.29% in FY2024 (+59.05 pp), -95.35% in FY2023 (+398.26 pp), -493.61% in FY2022 (+1517.28 pp) and -2010.89% in FY2021 (+21155.47 pp).
- Five-year quarterly EBITDA Margin spans a low of -6520.44% in Q4 2022 and a high of 65.80% in Q1 2025.
- Year over year, EBITDA Margin gained in six of the last eight quarters, with an average year-over-year change of -35.41 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q4 2021 (a gain of 20227.72 percentage points); the low point was Q4 2022 (a drop of 5480.30 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -496.66% (Q1 2026), 35.98% (Q4 2025) and 21.30% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.37 Bn | 1,139.96 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 645.23 Bn | 565.09 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 502.25 Bn | 475.37 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 361.34 Bn | 315.71 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 302.82 Bn | 266.81 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.91 Bn | 241.60 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 193.55 Bn | 167.74 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 172.05 Bn | 118.70 Bn | 10.94 Bn | 39.16% |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | -93.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -93.85% |
| Mar 31, 2026 | -496.66% |
| Dec 31, 2025 | 35.98% |
| Sep 30, 2025 | 21.30% |
| Jun 30, 2025 | -23.63% |
| Mar 31, 2025 | 65.80% |
| Dec 31, 2024 | -9.57% |
| Sep 30, 2024 | -47.44% |
| Jun 30, 2024 | -33.22% |
| Mar 31, 2024 | -78.60% |
| Dec 31, 2023 | -69.39% |
| Sep 30, 2023 | -68.76% |
| Jun 30, 2023 | -291.42% |
| Mar 31, 2023 | -57.39% |
| Dec 31, 2022 | -6,520.44% |
| Sep 30, 2022 | -289.97% |
| Jun 30, 2022 | -400.55% |
| Mar 31, 2022 | -674.29% |
| Dec 31, 2021 | -1,040.14% |
| Sep 30, 2021 | -2,517.58% |
API Access
Evofem Biosciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();